01 1AX Pharmaceutical Corp
02 2Cambrex Charles City, Inc
03 1Cipla Ltd.
04 1Esteve Huayi Pharmaceuticals Co., Ltd
05 1F.I.S. FABBRICA ITALIANA SINTETICI S.P.A.
06 1Hetero Labs Limited
07 2MSN Laboratories Private Limited
08 1Natco Pharma Limited
09 1SHILPA PHARMA LIFESCIENCES LIMITED
10 1Sichuan Xieli Pharmaceutical Co., Ltd.
11 2Sicor de Mexico S.A. de C.V
12 1VALARY LAB LIMITED
01 1ERLOTINIB HYDROCHLORIDE
02 2Erlotinib
03 3Erlotinib HCl
04 8Erlotinib Hydrochloride
05 1Erlotinib Hydrochloride (Form-B)
01 1Canada
02 2China
03 6India
04 1Italy
05 2Mexico
06 2U.S.A
07 1Blank
NDC Package Code : 59116-4250
Start Marketing Date : 2014-03-25
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59116-4251
Start Marketing Date : 2014-06-01
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 53104-7716
Start Marketing Date : 2016-01-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (25kg/25kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 59997-0003
Start Marketing Date : 2014-11-12
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 48087-0133
Start Marketing Date : 2022-09-14
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0012
Start Marketing Date : 2012-05-26
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 54893-0067
Start Marketing Date : 2017-12-29
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (1kg/kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 61200-013
Start Marketing Date : 2015-05-14
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER, FOR SUSPENSION (1kg/kg)
Marketing Category : BULK INGREDIENT FOR HUMAN P...
NDC Package Code : 63592-3400
Start Marketing Date : 2018-11-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 63592-3407
Start Marketing Date : 2018-11-05
End Marketing Date : 2025-12-31
Dosage Form (Strength) : POWDER (100kg/100kg)
Marketing Category : BULK INGREDIENT
A Erlotinib Hydrochloride manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Erlotinib Hydrochloride, including repackagers and relabelers. The FDA regulates Erlotinib Hydrochloride manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Erlotinib Hydrochloride API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Erlotinib Hydrochloride manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Erlotinib Hydrochloride supplier is an individual or a company that provides Erlotinib Hydrochloride active pharmaceutical ingredient (API) or Erlotinib Hydrochloride finished formulations upon request. The Erlotinib Hydrochloride suppliers may include Erlotinib Hydrochloride API manufacturers, exporters, distributors and traders.
click here to find a list of Erlotinib Hydrochloride suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Erlotinib Hydrochloride as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Erlotinib Hydrochloride API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Erlotinib Hydrochloride as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Erlotinib Hydrochloride and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Erlotinib Hydrochloride NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Erlotinib Hydrochloride suppliers with NDC on PharmaCompass.
We have 11 companies offering Erlotinib Hydrochloride
Get in contact with the supplier of your choice:
LOOKING FOR A SUPPLIER?
